PolySeq

Beijing, China · Founded 2021 · Privately Held (backing)

Developer of a nanopore sequencing platform for the purpose of the fourth-generation gene sequencer and supporting reagent consumables. PolySeq is based in Beijing, China and was founded in 2021. Its last reported valuation was $69.5 million in May 2023. It has raised $36.2 million.

Last reported valuation
$69.5M
Oct 2026
Priced at
—
Total raised
$36.2M
Last round
—

Who backs PolySeq?

9 investors
InvestorType
IDG CapitalVenture capital
Tsinghua Innovation VenturesVenture capital
BOC Financial Assets InvestmentGrowth equity
Chang DevelopmentOther
KSCY Holding GroupOther
Beijing Shangshi Investment Management—
Global Healthcare Innovation Center—
Guangzhou Wondfo Biotech—
Sanmei Investment—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

PolySeq investors

9 investors are on record for PolySeq, including IDG Capital, Tsinghua Innovation Ventures, BOC Financial Assets Investment and Chang Development.

Free account
More of PolySeq with a free account
  • ·Watch PolySeq: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like PolySeq. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View